Q9SGY2 ATP-citrate synthase alpha chain protein 1 MolNFT, Molecular NFT on GenesisL1

ATP-citrate synthase alpha chain protein 1

MOLNFT AF v1 smart contract in GenesisL1 blockchain:

0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD

IPFS of NFT metadata:

bafybeifypgcwlhhbozzpi2jtupiih6azis3oj6lmh35nipk26gukxlg4iu/metadata.json

IPFS of structure file:

bafybeiarqwaisrgchxpvqqrju27eyurev5td5kbyid7h6y2rrf77d32nai/AF-Q9SGY2-F1-model_v2.pdb

First NFT owner address (eip-55):

0x47141EE8158A0321829cdC551eFDDc824D2AF978

First NFT owner address (bech32):

genesis1gu2pa6q43gpjrq5um323alwusfxj47tcnuvv29

Current NFT ID #6321 owner (web3):

0x47141EE8158A0321829cdC551eFDDc824D2AF978

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
6321
Accession (UniProt):
Q9SGY2
Name::
ATP-citrate synthase alpha chain protein 1
Experimental Method:
Predicted structure
Sequence source:
ARABIDOPSIS THALIANA

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q9SGY2 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q9SGY2|ACLA1_ARATH ATP-citrate synthase alpha chain protein 1 OS=Arabidopsis thaliana OX=3702 GN=ACLA-1 PE=1 SV=1 MARKKIREYDSKRLVKEHFKRLSGKELPIRSVQINETTDLNELVEKEPWLSSEKLVVKPDMLFGKRGKSGLVALKLDFADVATFVKERLGKEVEMSGCKGPITTFIVEPFVPHNEEYYLNVVSDRLGCSISFSECGGIEIEENWDKVKTIFLPTGASLTPEICAPLVATLPLEIKAEIEEFIKVIFTLFQDLDFTFLEMNPFTLVDGSPYPLDMRGELDDTAAFKNFKKWGDIEFPLPFGRVMSPTESFIHGLDEKTSASLKFTVLNPKGRIWTMVAGGGASVIYADTVGDLGYASELGNYAEYSGAPKEDEVLQYARVVIDCATANPDGKSRALVIGGGIANFTDVAATFNGIIRALKEKEAKLKAARMHIFVRRGGPNYQKGLAKMRALGDDIGVPIEVYGPEATMTGICKEAIQYITAAA

Q9SGY2 AF NFT

MOLNFT AF v1

NFT data

MOLNFT Q9SGY2 research and analysis (ICN3D with VR)

FASTA sequences

We use cookies on this site to enhance your user experience